Home › Research › Topics › concordance
concordance
6 studies tagged concordance, dated 2014-01-01 to 2024-02-07. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 2024-02-07
- Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest 2021-03-04
- Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays 2021-02-06
Studies
6 studies carry this tag.
Date range
2014 to 2024
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 2
- Journal of Alzheimer's disease : JAD 2
- Alzheimer's & dementia (Amsterdam, Netherlands) 1
- Frontiers in aging neuroscience 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The identified cutoffs and probability-based models represent a significant step toward plasma AD molecular diagnosis.
-
Manual ELISA assays are the most commonly used methods for quantification of biomarkers; however, they often show inter- and intra-laboratory variability that limits their wide use.
-
The Lumipulse platform provides comparable sensitivity and specificity to established CSF immunoassays in identifying pre-symptomatic AD pathology.
-
This study verified the agreement between CSF and blood exosomal biomarkers and confirmed that exosomal Aβ42, T-tau, and P-T181-tau have the same capacity as those in CSF for the diagnosis of AD and aMCI.
-
This study confirms strong concordance between CSF biomarkers and PET Aβ-amyloid status is independent of immunoassay platform, supporting their utility as biomarkers in clinical practice for the diagnosis of AD and for participant enrichment in clinical trials.
-
47/100
Concordance between CSF Aβ42 and [11C]PIB PET was good in all diagnostic groups.